KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
73 hedge funds and large institutions have $905M invested in Kinnate Biopharma Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
+11
Holders Change %
+17.74%
% of All Funds
1.28%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
17
Increased
32
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BC
Boxer Capital
San Diego,
California
|
$42.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$42.9M |
| 3 |
BlackRock
New York
|
$43.1M |
| 4 |
Morgan Stanley
New York
|
$9.27M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
$11.5M |
